\n
\t\t\t\t\t\t| 英文名称 | \t\t\tCD95/FAS | \t\t
\t\t\t\t\t| 中文名称 | \t\t\t载脂蛋白1抗体 | \t\t
\t\t\t\t\t| 别\xa0\xa0\xa0\xa0名 | \t\t\tApo-1; ALPS 1A; ALPS1A; APO 1; Apo 1 antigen; APO 1 cell surface antigen; Apo-1 antigen; APO1; Apo1 antigen; APO1 cell surface antigen; Apoptosis antigen 1; Apoptosis mediating surface antigen FAS; Apoptosis-mediating surface antigen FAS; APT 1; APT1; CD 95; CD 95 antigen; CD95; CD95 antigen; Delta Fas; Delta Fas/APO 1/CD95; Delta Fas/APO1/CD95; FAS 1; FAS 827dupA; Fas AMA; FAS; FAS Antigen; FAS1; FASLG receptor; FASTM; TNF receptor superfamily, member 6; TNFRSF 6; TNFRSF6; TNR6_HUMAN; Tumor necrosis factor receptor superfamily member 6.\xa0\xa0 | \t\t
\t
\t
\t\t\t\t\t| 英文名称 | \t\t\tCD95/FAS | \t\t
\t\t\t\t\t| 中文名称 | \t\t\t载脂蛋白1抗体 | \t\t
\t\t\t\t\t| 别\xa0\xa0\xa0\xa0名 | \t\t\tApo-1; ALPS 1A; ALPS1A; APO 1; Apo 1 antigen; APO 1 cell surface antigen; Apo-1 antigen; APO1; Apo1 antigen; APO1 cell surface antigen; Apoptosis antigen 1; Apoptosis mediating surface antigen FAS; Apoptosis-mediating surface antigen FAS; APT 1; APT1; CD 95; CD 95 antigen; CD95; CD95 antigen; Delta Fas; Delta Fas/APO 1/CD95; Delta Fas/APO1/CD95; FAS 1; FAS 827dupA; Fas AMA; FAS; FAS Antigen; FAS1; FASLG receptor; FASTM; TNF receptor superfamily, member 6; TNFRSF 6; TNFRSF6; TNR6_HUMAN; Tumor necrosis factor receptor superfamily member 6.\xa0\xa0 | \t\t
\t\t\t
\t\t\t| 英文名称 | \t\t\tCD95/FAS | \t\t
\t\t\t
英文名称 | 英文名称\t\t\t
CD95/FAS | CD95/FAS\t\t\t\t
\t\t\t| 中文名称 | \t\t\t载脂蛋白1抗体 | \t\t
\t\t\t
中文名称 | 中文名称\t\t\t
载脂蛋白1抗体 | 载脂蛋白1抗体\t\t\t\t
\t\t\t| 别\xa0\xa0\xa0\xa0名 | \t\t\tApo-1; ALPS 1A; ALPS1A; APO 1; Apo 1 antigen; APO 1 cell surface antigen; Apo-1 antigen; APO1; Apo1 antigen; APO1 cell surface antigen; Apoptosis antigen 1; Apoptosis mediating surface antigen FAS; Apoptosis-mediating surface antigen FAS; APT 1; APT1; CD 95; CD 95 antigen; CD95; CD95 antigen; Delta Fas; Delta Fas/APO 1/CD95; Delta Fas/APO1/CD95; FAS 1; FAS 827dupA; Fas AMA; FAS; FAS Antigen; FAS1; FASLG receptor; FASTM; TNF receptor superfamily, member 6; TNFRSF 6; TNFRSF6; TNR6_HUMAN; Tumor necrosis factor receptor superfamily member 6.\xa0\xa0 | \t\t
\t\t\t
别\xa0\xa0\xa0\xa0名 | 别\xa0\xa0\xa0\xa0名\t\t\t
Apo-1; ALPS 1A; ALPS1A; APO 1; Apo 1 antigen; APO 1 cell surface antigen; Apo-1 antigen; APO1; Apo1 antigen; APO1 cell surface antigen; Apoptosis antigen 1; Apoptosis mediating surface antigen FAS; Apoptosis-mediating surface antigen FAS; APT 1; APT1; CD 95; CD 95 antigen; CD95; CD95 antigen; Delta Fas; Delta Fas/APO 1/CD95; Delta Fas/APO1/CD95; FAS 1; FAS 827dupA; Fas AMA; FAS; FAS Antigen; FAS1; FASLG receptor; FASTM; TNF receptor superfamily, member 6; TNFRSF 6; TNFRSF6; TNR6_HUMAN; Tumor necrosis factor receptor superfamily member 6.\xa0\xa0 | Apo-1; ALPS 1A; ALPS1A; APO 1; Apo 1 antigen; APO 1 cell surface antigen; Apo-1 antigen; APO1; Apo1 antigen; APO1 cell surface antigen; Apoptosis antigen 1; Apoptosis mediating surface antigen FAS; Apoptosis-mediating surface antigen FAS; APT 1; APT1; CD 95; CD 95 antigen; CD95; CD95 antigen; Delta Fas; Delta Fas/APO 1/CD95; Delta Fas/APO1/CD95; FAS 1; FAS 827dupA; Fas AMA; FAS; FAS Antigen; FAS1; FASLG receptor; FASTM; TNF receptor superfamily, member 6; TNFRSF 6; TNFRSF6; TNR6_HUMAN; Tumor necrosis factor receptor superfamily member 6.\xa0\xa0\t\t\t
\xa0
\xa0
\xa0
\xa0
\xa0
\xa0
\t\t\t\t\t\t| 研究领域 | \t\t\t细胞生物\xa0\xa0免疫学\xa0\xa0细胞凋亡\xa0\xa0 | \t\t
\t\t\t\t\t| 抗体来源 | \t\t\tRabbit | \t\t
\t\t\t\t\t| 克隆类型 | \t\t\tPolyclonal | \t\t
\t\t\t\t\t| 交叉反应 | \t\t\tHuman,\xa0Mouse,\xa0Rat,\xa0 (predicted: Pig,\xa0) | \t\t
\t\t\t\t\t| 产品应用 | \t\t\tWB=1:500-2000\xa0ELISA=1:5000-10000\xa0Flow-Cyt=1μg/Test\xa0 \t\t\tnot yet tested in other applications. \t\t\toptimal dilutions/concentrations should be determined by the end user. | \t\t
\t\t\t\t\t| 分\xa0子\xa0量 | \t\t\t34kDa | \t\t
\t\t\t\t\t| 细胞定位 | \t\t\t细胞膜\xa0分泌型蛋白\xa0 | \t\t
\t\t\t\t\t| 性\xa0\xa0\xa0\xa0状 | \t\t\tLiquid | \t\t
\t\t\t\t\t| 浓\xa0\xa0\xa0\xa0度 | \t\t\t1mg/ml | \t\t
\t\t\t\t\t| 免\xa0疫\xa0原 | \t\t\tKLH conjugated synthetic peptide derived from human FAS/Apo-1/CD95:81-170/335\xa0<Extracellular> | \t\t
\t\t\t\t\t| 亚\xa0\xa0\xa0\xa0型 | \t\t\tIgG | \t\t
\t\t\t\t\t| 纯化方法 | \t\t\taffinity purified by Protein A | \t\t
\t\t\t\t\t| 储\xa0存\xa0液 | \t\t\t0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. | \t\t
\t\t\t\t\t| 保存条件 | \t\t\tShipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. | \t\t
\t\t\t\t\t| PubMed | \t\t\tPubMed | \t\t
\t\t\t\t\t| 产品介绍 | \t\t\tReceptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). \t\t\t \t\t\tFunction: \t\t\tReceptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). \t\t\t \t\t\tSubunit: \t\t\tBinds DAXX. Interacts with HIPK3. Part of a complex containing HIPK3 and FADD. Binds RIPK1 and FAIM2. Interacts with BRE and FEM1B. Interacts with FADD. \t\t\t \t\t\tSubcellular Location: \t\t\tIsoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2, 3, 4, 5, 6: Secreted. \t\t\t \t\t\tTissue Specificity: \t\t\tIsoform 1 and isoform 6 are expressed at equal levels in resting peripheral blood mononuclear cells. After activation there is an increase in isoform 1 and decrease in the levels of isoform 6. \t\t\t \t\t\tPost-translational modifications: \t\t\tN- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans. \t\t\t \t\t\tDISEASE: \t\t\tDefects in FAS are the cause of autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859]; also known as Canale-Smith syndrome (CSS). ALPS is a childhood syndrome involving hemolytic anemia and thrombocytopenia with massive lymphadenopathy and splenomegaly. \t\t\t \t\t\tSimilarity: \t\t\tContains 1 death domain. \t\t\tContains 3 TNFR-Cys repeats. \t\t\t \t\t\tSWISS: \t\t\tP25445 \t\t\t \t\t\tGene ID: \t\t\t355 \t\t\t \t\t\tDatabase links:\t\t\tEntrez Gene: 355\xa0Human \t\t\tEntrez Gene: 14102\xa0Mouse \t\t\tEntrez Gene: 246097\xa0Rat \t\t\tOmim: 134637\xa0Human \t\t\tSwissProt: P25445\xa0Human \t\t\tSwissProt: P25446\xa0Mouse \t\t\tSwissProt: Q63199\xa0Rat \t\t\tUnigene: 244139\xa0Human \t\t\tUnigene: 1626\xa0Mouse \t\t\tUnigene: 162521\xa0Rat \t\t\t \t\t\t \t\t\tImportant Note: \t\t\tThis product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications | \t\t
\t
\t
\t\t\t\t\t| 研究领域 | \t\t\t细胞生物\xa0\xa0免疫学\xa0\xa0细胞凋亡\xa0\xa0 | \t\t
\t\t\t\t\t| 抗体来源 | \t\t\tRabbit | \t\t
\t\t\t\t\t| 克隆类型 | \t\t\tPolyclonal | \t\t
\t\t\t\t\t| 交叉反应 | \t\t\tHuman,\xa0Mouse,\xa0Rat,\xa0 (predicted: Pig,\xa0) | \t\t
\t\t\t\t\t| 产品应用 | \t\t\tWB=1:500-2000\xa0ELISA=1:5000-10000\xa0Flow-Cyt=1μg/Test\xa0 \t\t\tnot yet tested in other applications. \t\t\toptimal dilutions/concentrations should be determined by the end user. | \t\t
\t\t\t\t\t| 分\xa0子\xa0量 | \t\t\t34kDa | \t\t
\t\t\t\t\t| 细胞定位 | \t\t\t细胞膜\xa0分泌型蛋白\xa0 | \t\t
\t\t\t\t\t| 性\xa0\xa0\xa0\xa0状 | \t\t\tLiquid | \t\t
\t\t\t\t\t| 浓\xa0\xa0\xa0\xa0度 | \t\t\t1mg/ml | \t\t
\t\t\t\t\t| 免\xa0疫\xa0原 | \t\t\tKLH conjugated synthetic peptide derived from human FAS/Apo-1/CD95:81-170/335\xa0<Extracellular> | \t\t
\t\t\t\t\t| 亚\xa0\xa0\xa0\xa0型 | \t\t\tIgG | \t\t
\t\t\t\t\t| 纯化方法 | \t\t\taffinity purified by Protein A | \t\t
\t\t\t\t\t| 储\xa0存\xa0液 | \t\t\t0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. | \t\t
\t\t\t\t\t| 保存条件 | \t\t\tShipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. | \t\t
\t\t\t\t\t| PubMed | \t\t\tPubMed | \t\t
\t\t\t\t\t| 产品介绍 | \t\t\tReceptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). \t\t\t \t\t\tFunction: \t\t\tReceptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). \t\t\t \t\t\tSubunit: \t\t\tBinds DAXX. Interacts with HIPK3. Part of a complex containing HIPK3 and FADD. Binds RIPK1 and FAIM2. Interacts with BRE and FEM1B. Interacts with FADD. \t\t\t \t\t\tSubcellular Location: \t\t\tIsoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2, 3, 4, 5, 6: Secreted. \t\t\t \t\t\tTissue Specificity: \t\t\tIsoform 1 and isoform 6 are expressed at equal levels in resting peripheral blood mononuclear cells. After activation there is an increase in isoform 1 and decrease in the levels of isoform 6. \t\t\t \t\t\tPost-translational modifications: \t\t\tN- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans. \t\t\t \t\t\tDISEASE: \t\t\tDefects in FAS are the cause of autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859]; also known as Canale-Smith syndrome (CSS). ALPS is a childhood syndrome involving hemolytic anemia and thrombocytopenia with massive lymphadenopathy and splenomegaly. \t\t\t \t\t\tSimilarity: \t\t\tContains 1 death domain. \t\t\tContains 3 TNFR-Cys repeats. \t\t\t \t\t\tSWISS: \t\t\tP25445 \t\t\t \t\t\tGene ID: \t\t\t355 \t\t\t \t\t\tDatabase links:\t\t\tEntrez Gene: 355\xa0Human \t\t\tEntrez Gene: 14102\xa0Mouse \t\t\tEntrez Gene: 246097\xa0Rat \t\t\tOmim: 134637\xa0Human \t\t\tSwissProt: P25445\xa0Human \t\t\tSwissProt: P25446\xa0Mouse \t\t\tSwissProt: Q63199\xa0Rat \t\t\tUnigene: 244139\xa0Human \t\t\tUnigene: 1626\xa0Mouse \t\t\tUnigene: 162521\xa0Rat \t\t\t \t\t\t \t\t\tImportant Note: \t\t\tThis product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications | \t\t
\t\t\t
\t\t\t| 研究领域 | \t\t\t细胞生物\xa0\xa0免疫学\xa0\xa0细胞凋亡\xa0\xa0 | \t\t
\t\t\t
研究领域 | 研究领域\t\t\t
细胞生物\xa0\xa0免疫学\xa0\xa0细胞凋亡\xa0\xa0 | 细胞生物细胞生物\xa0\xa0
免疫学免疫学\xa0\xa0
细胞凋亡细胞凋亡\xa0\xa0\t\t\t\t
\t\t\t| 抗体来源 | \t\t\tRabbit | \t\t
\t\t\t
抗体来源 | 抗体来源\t\t\t
Rabbit | Rabbit\t\t\t\t
\t\t\t| 克隆类型 | \t\t\tPolyclonal | \t\t
\t\t\t
克隆类型 | 克隆类型\t\t\t
Polyclonal | Polyclonal\t\t\t\t
\t\t\t| 交叉反应 | \t\t\tHuman,\xa0Mouse,\xa0Rat,\xa0 (predicted: Pig,\xa0) | \t\t
\t\t\t
交叉反应 | 交叉反应\t\t\t
Human,\xa0Mouse,\xa0Rat,\xa0 (predicted: Pig,\xa0) | Human,\xa0Mouse,\xa0Rat,\xa0 (predicted: Pig,\xa0)\t\t\t\t
\t\t\t| 产品应用 | \t\t\tWB=1:500-2000\xa0ELISA=1:5000-10000\xa0Flow-Cyt=1μg/Test\xa0 \t\t\tnot yet tested in other applications. \t\t\toptimal dilutions/concentrations should be determined by the end user. | \t\t
\t\t\t
产品应用 | 产品应用\t\t\t
WB=1:500-2000\xa0ELISA=1:5000-10000\xa0Flow-Cyt=1μg/Test\xa0 \t\t\tnot yet tested in other applications. \t\t\toptimal dilutions/concentrations should be determined by the end user. | WB=1:500-2000\xa0ELISA=1:5000-10000\xa0Flow-Cyt=1μg/Test\xa0
\t\t\tnot yet tested in other applications.
\t\t\toptimal dilutions/concentrations should be determined by the end user.\t\t\t\t
\t\t\t| 分\xa0子\xa0量 | \t\t\t34kDa | \t\t
\t\t\t
分\xa0子\xa0量 | 分\xa0子\xa0量\t\t\t
34kDa | 34kDa\t\t\t\t
\t\t\t| 细胞定位 | \t\t\t细胞膜\xa0分泌型蛋白\xa0 | \t\t
\t\t\t
细胞定位 | 细胞定位\t\t\t
细胞膜\xa0分泌型蛋白\xa0 | 细胞膜\xa0分泌型蛋白\xa0\t\t\t\t
\t\t\t| 性\xa0\xa0\xa0\xa0状 | \t\t\tLiquid | \t\t
\t\t\t
性\xa0\xa0\xa0\xa0状 | 性\xa0\xa0\xa0\xa0状\t\t\t
Liquid | Liquid\t\t\t\t
\t\t\t| 浓\xa0\xa0\xa0\xa0度 | \t\t\t1mg/ml | \t\t
\t\t\t
浓\xa0\xa0\xa0\xa0度 | 浓\xa0\xa0\xa0\xa0度\t\t\t
1mg/ml | 1mg/ml\t\t\t\t
\t\t\t| 免\xa0疫\xa0原 | \t\t\tKLH conjugated synthetic peptide derived from human FAS/Apo-1/CD95:81-170/335\xa0<Extracellular> | \t\t
\t\t\t
免\xa0疫\xa0原 | 免\xa0疫\xa0原\t\t\t
KLH conjugated synthetic peptide derived from human FAS/Apo-1/CD95:81-170/335\xa0<Extracellular> | KLH conjugated synthetic peptide derived from human FAS/Apo-1/CD95:81-170/335\xa0
\t\t\t\t\t\t\t| 亚\xa0\xa0\xa0\xa0型 | \t\t\tIgG | \t\t
\t\t\t亚\xa0\xa0\xa0\xa0型 | 亚\xa0\xa0\xa0\xa0型\t\t\tIgG | IgG\t\t\t\t\t\t\t| 纯化方法 | \t\t\taffinity purified by Protein A | \t\t
\t\t\t纯化方法 | 纯化方法\t\t\taffinity purified by Protein A | affinity purified by Protein A\t\t\t\t\t\t\t| 储\xa0存\xa0液 | \t\t\t0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. | \t\t
\t\t\t储\xa0存\xa0液 | 储\xa0存\xa0液\t\t\t0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.\t\t\t\t\t\t\t| 保存条件 | \t\t\tShipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. | \t\t
\t\t\t保存条件 | 保存条件\t\t\tShipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.\t\t\t\t\t\t\t| PubMed | \t\t\tPubMed | \t\t
\t\t\tPubMed | PubMed\t\t\tPubMed | PubMedPubMed\t\t\t\t\t\t\t| 产品介绍 | \t\t\tReceptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). \t\t\t \t\t\tFunction: \t\t\tReceptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). \t\t\t \t\t\tSubunit: \t\t\tBinds DAXX. Interacts with HIPK3. Part of a complex containing HIPK3 and FADD. Binds RIPK1 and FAIM2. Interacts with BRE and FEM1B. Interacts with FADD. \t\t\t \t\t\tSubcellular Location: \t\t\tIsoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2, 3, 4, 5, 6: Secreted. \t\t\t \t\t\tTissue Specificity: \t\t\tIsoform 1 and isoform 6 are expressed at equal levels in resting peripheral blood mononuclear cells. After activation there is an increase in isoform 1 and decrease in the levels of isoform 6. \t\t\t \t\t\tPost-translational modifications: \t\t\tN- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans. \t\t\t \t\t\tDISEASE: \t\t\tDefects in FAS are the cause of autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859]; also known as Canale-Smith syndrome (CSS). ALPS is a childhood syndrome involving hemolytic anemia and thrombocytopenia with massive lymphadenopathy and splenomegaly. \t\t\t \t\t\tSimilarity: \t\t\tContains 1 death domain. \t\t\tContains 3 TNFR-Cys repeats. \t\t\t \t\t\tSWISS: \t\t\tP25445 \t\t\t \t\t\tGene ID: \t\t\t355 \t\t\t \t\t\tDatabase links:\t\t\tEntrez Gene: 355\xa0Human \t\t\tEntrez Gene: 14102\xa0Mouse \t\t\tEntrez Gene: 246097\xa0Rat \t\t\tOmim: 134637\xa0Human \t\t\tSwissProt: P25445\xa0Human \t\t\tSwissProt: P25446\xa0Mouse \t\t\tSwissProt: Q63199\xa0Rat \t\t\tUnigene: 244139\xa0Human \t\t\tUnigene: 1626\xa0Mouse \t\t\tUnigene: 162521\xa0Rat \t\t\t \t\t\t \t\t\tImportant Note: \t\t\tThis product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications | \t\t
\t\t\t产品介绍 | 产品介绍\t\t\tReceptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). \t\t\t \t\t\tFunction: \t\t\tReceptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). \t\t\t \t\t\tSubunit: \t\t\tBinds DAXX. Interacts with HIPK3. Part of a complex containing HIPK3 and FADD. Binds RIPK1 and FAIM2. Interacts with BRE and FEM1B. Interacts with FADD. \t\t\t \t\t\tSubcellular Location: \t\t\tIsoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2, 3, 4, 5, 6: Secreted. \t\t\t \t\t\tTissue Specificity: \t\t\tIsoform 1 and isoform 6 are expressed at equal levels in resting peripheral blood mononuclear cells. After activation there is an increase in isoform 1 and decrease in the levels of isoform 6. \t\t\t \t\t\tPost-translational modifications: \t\t\tN- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans. \t\t\t \t\t\tDISEASE: \t\t\tDefects in FAS are the cause of autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859]; also known as Canale-Smith syndrome (CSS). ALPS is a childhood syndrome involving hemolytic anemia and thrombocytopenia with massive lymphadenopathy and splenomegaly. \t\t\t \t\t\tSimilarity: \t\t\tContains 1 death domain. \t\t\tContains 3 TNFR-Cys repeats. \t\t\t \t\t\tSWISS: \t\t\tP25445 \t\t\t \t\t\tGene ID: \t\t\t355 \t\t\t \t\t\tDatabase links:\t\t\tEntrez Gene: 355\xa0Human \t\t\tEntrez Gene: 14102\xa0Mouse \t\t\tEntrez Gene: 246097\xa0Rat \t\t\tOmim: 134637\xa0Human \t\t\tSwissProt: P25445\xa0Human \t\t\tSwissProt: P25446\xa0Mouse \t\t\tSwissProt: Q63199\xa0Rat \t\t\tUnigene: 244139\xa0Human \t\t\tUnigene: 1626\xa0Mouse \t\t\tUnigene: 162521\xa0Rat \t\t\t \t\t\t \t\t\tImportant Note: \t\t\tThis product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications | Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro).
\t\t\t
\t\t\tFunction:
\t\t\tReceptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro).
\t\t\t
\t\t\tSubunit:
\t\t\tBinds DAXX. Interacts with HIPK3. Part of a complex containing HIPK3 and FADD. Binds RIPK1 and FAIM2. Interacts with BRE and FEM1B. Interacts with FADD.
\t\t\t
\t\t\tSubcellular Location:
\t\t\tIsoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2, 3, 4, 5, 6: Secreted.
\t\t\t
\t\t\tTissue Specificity:
\t\t\tIsoform 1 and isoform 6 are expressed at equal levels in resting peripheral blood mononuclear cells. After activation there is an increase in isoform 1 and decrease in the levels of isoform 6.
\t\t\t
\t\t\tPost-translational modifications:
\t\t\tN- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans.
\t\t\t
\t\t\tDISEASE:
\t\t\tDefects in FAS are the cause of autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859]; also known as Canale-Smith syndrome (CSS). ALPS is a childhood syndrome involving hemolytic anemia and thrombocytopenia with massive lymphadenopathy and splenomegaly.
\t\t\t
\t\t\tSimilarity:
\t\t\tContains 1 death domain.
\t\t\tContains 3 TNFR-Cys repeats.
\t\t\t
\t\t\tSWISS:
\t\t\tP25445
\t\t\t
\t\t\tGene ID:
\t\t\t355
\t\t\t
\t\t\tDatabase links:\t\t\tEntrez Gene: 355\xa0Human
Entrez Gene: 355Entrez Gene: 355\xa0Human\t\t\tEntrez Gene: 14102\xa0Mouse
Entrez Gene: 14102Entrez Gene: 14102\xa0Mouse\t\t\tEntrez Gene: 246097\xa0Rat
Entrez Gene: 246097Entrez Gene: 246097\xa0Rat\t\t\tOmim: 134637\xa0Human
Omim: 134637Omim: 134637\xa0Human\t\t\tSwissProt: P25445\xa0Human
SwissProt: P25445SwissProt: P25445\xa0Human\t\t\tSwissProt: P25446\xa0Mouse
SwissProt: P25446SwissProt: P25446\xa0Mouse\t\t\tSwissProt: Q63199\xa0Rat
SwissProt: Q63199SwissProt: Q63199\xa0Rat\t\t\tUnigene: 244139\xa0Human
Unigene: 244139Unigene: 244139\xa0Human\t\t\tUnigene: 1626\xa0Mouse
Unigene: 1626Unigene: 1626\xa0Mouse\t\t\tUnigene: 162521\xa0Rat
Unigene: 162521Unigene: 162521\xa0Rat\t\t\t
\t\t\t
\t\t\tImportant Note:
\t\t\tThis product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications\t\t\t\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0\xa0
\xa0




